A second study investigated CSF samples from asymptomatic (n = 14), symptomatic (n = 14), ALS mutation carriers (SOD1, C9ORF72 and TARDBP), and sporadic ALS patients (n = 12) [97]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.